Evolv Technologies Holdings, INC
Market Movers (8-K)
NASDAQ
Evolv Technologies Holdings, Inc. issued a Form 8-K to clarify misreported financial results and guidance for the first quarter of 2026.
NASDAQ
Evolv Technologies announced first quarter 2026 financial results, showcasing significant revenue growth and an improved Adjusted EBITDA, leading to an optimistic revised outlook for the full year 2026.
Better than expected
NASDAQ
Evolv Technologies Holdings, Inc. announced the appointment of Henrik Khl to its Board of Directors and Audit Committee, following the resignation of long-serving director Bilal Zuberi.
NASDAQ
Evolv Technologies announced robust third-quarter financial results, driven by significant revenue growth and increased annual recurring revenue, leading to an upward revision of its full-year 2025 revenue guidance.
Better than expected
Capital raise
NASDAQ
Evolv Technologies Holdings, Inc. reported strong second-quarter financial results, including a 29% revenue increase and positive Adjusted EBITDA, leading to an upward revision of its full-year 2025 revenue growth forecast.
Better than expected
NASDAQ
Evolv Technologies Holdings, Inc. has secured a new $75 million credit facility from MidCap Financial, comprising term and revolving loans, to support its growing long-term subscription sales model and general corporate purposes.
Capital raise
Quarterly Earnings (10-Q)
NASDAQ
Evolv Technologies Holdings, Inc. reported a significant revenue increase in Q3 2025, driven by strong product and subscription growth, while narrowing its net loss and securing new debt financing.
Capital raise
Better than expected
NASDAQ
Evolv Technologies Holdings, Inc. reported a significantly wider net loss for the first half of 2025, driven by fair value adjustments and increased operating expenses, despite strong revenue growth and improved operating cash flow, while also detailing ongoing legal and regulatory challenges and a new $75 million credit facility.
Worse than expected
Capital raise
Delay expected
NASDAQ
Evolv Technologies' Q1 2025 shows revenue growth driven by subscription services, while the company continues to address internal control weaknesses and legal challenges.
Capital raise
Better than expected
NASDAQ
10-Q: Evolv Technologies Restates Financials Amid Sales Practice Investigation, Reports Q3 2024 Results
Evolv Technologies restates prior financial statements due to revenue recognition errors stemming from sales practice irregularities, while also reporting a net loss for Q3 2024.
Worse than expected
Capital raise
Delay expected
NASDAQ
Evolv Technologies Holdings saw a significant shift in revenue mix in Q2 2024, with subscription revenue doubling year-over-year, while product revenue declined sharply.
Better than expected
Capital raise
NASDAQ
Evolv Technologies' first quarter 2024 results show a 17% increase in revenue year-over-year, despite a net loss and ongoing regulatory investigations.
Worse than expected
Capital raise
Annual Reports (10-K)
NASDAQ
Evolv Technologies Holdings restates past financial statements following an investigation into sales practices and revenue recognition.
Delay expected
Worse than expected
NASDAQ
10-K: Evolv Technologies Holdings, Inc. Reports 2023 Financial Results, Cites Growth in Subscription Model
Evolv Technologies Holdings, Inc. released its 2023 annual report, highlighting a shift towards a subscription-based revenue model and continued growth in deployments.
Capital raise
Worse than expected
Insider Trading (Form 4)
NASDAQ
Michael Ellenbogen, a Director of Evolv Technologies Holdings, Inc., sold 80,745 shares of common stock on July 15, 2026 for $5.94 per share.
NASDAQ
Director Michael Ellenbogen reported transactions involving Evolv Technologies Holdings, Inc. (EVLV) Class A Common Stock, including acquisitions and dispositions.
NASDAQ
Evolv Technologies Holdings, Inc. reports a Form 4 filing detailing stock transactions by Chief Revenue Officer Robert E. Marshall.
NASDAQ
Director Michael Ellenbogen reported transactions involving Evolv Technologies Holdings, Inc. Class A Common Stock and stock options on May 15, 2026, executed under a Rule 10b5-1 trading plan.
NASDAQ
Evolv Technologies Holdings, Inc. Chief Financial Officer George Kutsor reported the sale of 51,448 shares of Class A Common Stock to cover withholding taxes related to the vesting of Restricted Stock Units.
NASDAQ
Evolv Technologies Director Michael Ellenbogen exercised options and sold 80,745 shares of Class A Common Stock.
Proxy Statements (Def-14A)
NASDAQ
Evolv Technologies Holdings, Inc. announces its 2025 Annual Meeting and provides details on voting procedures and proposals.
NASDAQ
Evolv Technologies Holdings announces a 31% increase in 2024 revenue, reaching $103.9 million, alongside significant improvements in adjusted EBITDA and a strengthened corporate governance framework.
Better than expected
Delay expected
NASDAQ
Evolv Technologies Holdings, Inc. will hold its 2024 Annual Meeting of Stockholders on May 31, 2024, to vote on director elections, auditor ratification, officer exculpation, executive compensation, and other business.
NASDAQ
DEF 14A: Evolv Technologies Holdings, Inc. Announces Annual Meeting of Stockholders and Proxy Statement
Evolv Technologies Holdings, Inc. has released its proxy statement for the upcoming Annual Meeting of Stockholders to be held on May 31, 2024, covering proposals ranging from director elections to executive compensation and corporate governance matters.
Schedule 13D - Activist Investments
NASDAQ
Data Collective IV, L.P. and its affiliates have reduced their beneficial ownership in Evolv Technologies Holdings, Inc. to 4.7% through a series of open market sales.
Worse than expected
NASDAQ
Stoic Point Capital Management and its principals have reduced their beneficial ownership in Evolv Technologies Holdings, Inc. to 3.1% of Class A Common Stock.
Worse than expected
NASDAQ
Stoic Point Capital Management LLC, along with Rajiv P. Shah and Cullen J. Rose, has disclosed a 5.2% beneficial ownership stake in Evolv Technologies Holdings, Inc., acquired for investment purposes with an intent to engage management on maximizing shareholder value.
Schedule 13G - Passive Investments
NASDAQ
General Catalyst entities have filed an amendment to their Schedule 13G, reporting a 0% beneficial ownership stake in Evolv Technologies Holdings, Inc.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Evolv Technologies Holdings Inc. following an internal realignment.
NASDAQ
The Vanguard Group reported an increased passive ownership stake of 6.97% in Evolv Technologies Holdings Inc., holding nearly 12 million shares.
NASDAQ
Gates Frontier, LLC and William H. Gates III report a passive 1.4% beneficial ownership in Evolv Technologies Holdings, Inc. Class A common stock.